Vedolizumab Experience in Children and Adolescents With Inflammatory Bowel Disease: A Multicenter Observational Study

BACKGROUND: Vedolizumab is increasingly used off-label to treat children and adolescents with inflammatory bowel disease (IBD). In the absence of rigorous clinical trial experience, multicenter observational data are important to establish expectations for efficacy and safety. We examined 1-year out...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajjat, Temara M, Mosha, Maua, Whaley, Kaitlin G, Rosen, Michael J, Suppa, Carmine, Markowitz, James, Dufour, Lauren, Sauer, Cary, Shukla-Udawatta, Monica, Boyle, Brendan, Gibson, Meghan, Shapiro, Jason, Sams, Derica, Sylvester, Francisco, Hunter, Gabriele, Perez, Maria E, Hyams, Jeffrey S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802305/
https://www.ncbi.nlm.nih.gov/pubmed/36776669
http://dx.doi.org/10.1093/crocol/otab039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802305/
https://www.ncbi.nlm.nih.gov/pubmed/36776669
http://dx.doi.org/10.1093/crocol/otab039

Ejemplares similares